Blood Glucose Control in Type 2 Diabetic patients. Type 2 diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Male and female subjects between 20 and 70 years of age Noninsulin-dependent diabetes minimum of 2 years before the study enrollment Patients with diabetes Type 2 and on any antidiabetic medication (oral hypoglycemic agent, insulin) Patients willing to give informed consent Patients with out other comorbid conditions (cardiac, renal, macrovascular and microvascular complication) Non Gangren's diabetic foot ulcer Not Currently pregnant or breastfeeding, fertile women with out using any contraceptives methods Current daily tobacco smoker and Alcohol consumption with out any decision to change diet and physical style Not having a history of cancer less than 5 years and a depression
Exclusion criteria
Exclusion criteria: Evidence of any unwanted side effects of the drug include increased liver enzymes or functional renal dysfunction or Lower blood glucose control in the requested serial tests Evidence of any unwanted gastrointestinal discomfort, such as diarrhea, nausea, or gastrointestinal intolerance of the combined medication Any unwillingness of participants to continue to participate in the plan
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting Blood Glucose. Timepoint: Before, at the first of study, daily for 3 days, once 2days for 4 days , on the days of 15, 30, 45 and 60. Method of measurement: patients with check fasting blood glucose with Glucometer at Home. | — |
Secondary
| Measure | Time frame |
|---|---|
| Liver Function Test. Timepoint: Before, After, At the end of first month, At the end of second month. Method of measurement: Liver Function Tests. | — |
Countries
Iran (Islamic Republic of)
Contacts
Bagheiat-allah University of Medical Sciences